Explore / Peer-reviewed article
Peer-reviewed article

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Yaden DB, Berghella APiD, Hendricks PSiD, Yaden ME, Levine MiD, Rohde JSiD, Nayak S, Johnson MW, Garcia-Romeu AiD

Pharmacological researchNov 28, 2023United States6 citationsDOI: 10.1016/j.phrs.2023.106998

Abstract

Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is possible that these treatments will become legally available options for patients with SUDs in the future. This article highlights how classic psychedelic-assisted therapies might be integrated into current clinical practice. We first describe contemporary evidence-based treatments for SUDs and highlight how classic psychedelic-assisted therapies might fit within each treatment. We suggest that classic psychedelic-assisted therapies can be integrated into most mainstream evidence-based SUD treatments that are currently used in clinical settings, indicating broad compatibility of classic psychedelics with contemporary SUD treatment paradigms.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

Substance Use DisorderMedication Assisted TreatmentPsychedelics

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.